Achieve Life Sciences ACHV
NASDAQ ACHV
$8.49 +0.18 (+2.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2023)

Achieve Life Sciences' (ACHV) quarterly Receivables - Other came in at $32000.0 in Q4 2016, down 71.17% YoY from $111000.0 in Q1 2016, and down 11.11% on a QoQ basis from $36000.0 in Q3 2016.

Analysis

Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2023) Analysis & Trends

Achieve Life Sciences (ACHV) has 6 years of Receivables - Other data on file, last reported at $32000.0 in Q4 2016.

  • Quarterly Receivables - Other fell 71.17% year-over-year to $32000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $32000.0 (down 71.17% YoY) and the FY2016 annual result came in at $32000.0, down 71.17% from the prior year.
  • Receivables - Other declined to $32000.0 in Q4 2016, from $36000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $327000.0 in Q4 2012 to a low of $19000.0 in Q3 2014.
  • A 5-year average of $139562.5 and a median of $93500.0 in 2015 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2014 — Receivables - Other plunged 93.56% — and 2015, when it surged 152.63%.
  • Tracing ACHV's Receivables - Other over 5 years: stood at $327000.0 in 2012, then plunged by 33.33% to $218000.0 in 2013, then plunged by 48.17% to $113000.0 in 2014, then decreased by 1.77% to $111000.0 in 2015, then tumbled by 71.17% to $32000.0 in 2016.
  • The last three Receivables - Other figures came in at $32000.0 (Q4 2016), $36000.0 (Q3 2016), and $47000.0 (Q2 2016), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Achieve Life Sciences 369.90 Mn 369.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 111,000.00
Sep 30, 2023 83,000.00
Jun 30, 2023 350,000.00
Mar 31, 2023 89,000.00
Dec 31, 2022 105,000.00
Sep 30, 2022 145,000.00
Jun 30, 2022 313,000.00
Dec 31, 2021 153,000.00
Sep 30, 2021 151,000.00
Dec 31, 2016 32,000.00
Sep 30, 2016 36,000.00
Jun 30, 2016 47,000.00
Mar 31, 2016 53,000.00
Dec 31, 2015 111,000.00
Sep 30, 2015 48,000.00
Jun 30, 2015 76,000.00
Mar 31, 2015 71,000.00
Dec 31, 2014 113,000.00
Sep 30, 2014 19,000.00
Mar 31, 2014 166,000.00